Skip to main content

Sami B. Ghneim advises public and pre-IPO companies on capital markets and corporate governance matters and compliance with securities laws. He represents issuers in a range of financing transactions, including equity and debt offerings, liability management, and private placements. Sami advises clients on a wide variety of securities laws and governance matters, including drafting and reviewing annual, periodic and current reports and proxy statements, compliance with SEC/stock exchange rules and board meeting minutes, as well as with respect to day-to-day operational matters, including contract review, covenant compliance, internal restructurings, intercompany arrangements, and investor communications. Sami also has experience representing underwriters, initial purchasers, and placement agents in a wide variety of public and private financing transactions.

Concentrations

  • Public and private equity and debt capital markets, including IPOs and follow-on equity offerings, private placements, PIPEs, convertible notes, investment grade and high yield debt, and exchange offers
  • SEC and stock exchange reporting, corporate governance, and compliance obligations for both domestic and foreign private issuers
  • Mergers and acquisitions
  • SPACs

Capabilities

Experience

  • Represented Entera Bio Ltd. (Nasdaq: ENTX) in its private placement offering of common stock and warrants for up to approximately $16 million in gross proceeds.
  • Represented US Data Mining Group, Inc. dba US Bitcoin Corp., a builder and strategic operator of Bitcoin mining centers across the United States, in an all-stock merger of equals with Hut 8 Mining (Nasdaq: HUT) (TSX: HUT), a large, innovation-focused digital asset mining pioneer and high-performance computing infrastructure provider.
  • Represented Flora Growth in multiple capital raising transactions, including a registered public offering and registered direct offering.
  • Represented placement agents in various private placement transactions for private and public companies.
  • Represented issuers in the establishment and continuance of at-the-market (ATM) offerings.
  • Acted as company counsel in connection with $50M initial public offering of a biotechnology company.°
  • Acted as company counsel in connection with $225M shelf takedown primary follow-on offering of a biotechnology company.°
  • Acted as company counsel in connection $70M initial public offering of a foreign private issuer biotechnology company.°
  • Represented an existing public company in connection with its spinoff and $352M IPO of its online gaming segment.°
  • Represented various issuers and initial purchasers in connection with registered and Rule 144/Reg S high yield and investment grade bond offerings.°
  • Represented various underwriters and placement agents in connection with IPOs, follow-on offerings, block trades and debt transactions.°

°The above representations were handled by Mr. Ghneim prior to his joining Greenberg Traurig, P.A.

  • Ongoing representation of several NYSE- and Nasdaq-traded public companies
  • Equity Capital Markets Secondee, BofA Securities, Inc., 2019
  • General Counsel Intern, International Speedway Corporation, 2014

Credentials

Education
  • J.D., cum laude, Duke University School of Law, 2016
    • Staff Editor, Duke Journal of Constitutional Law & Public Policy
  • B.S., Finance, cum laude, University of Florida, 2013
Admissions
  • Florida
  • New York
Languages
  • Arabic, Conversational